Join the Bipolar Disorder group to help and get support from people like you.
Bipolar Disorder News
Related terms: Bipolar Affective Disorder, Bipolar Affective Mood Disorder, Bipolar I Disorder, Manic Depression, Manic Depressive Disorder, Manic Depressive Illness, Mood Disorder, Bipolar, Bipolar Depression, Ultra Rapid Cycling, Bipolar II Disorder
Chronic Exposure to Systemic Inflammation May Increase Risk for Affective Disorders
THURSDAY, July 3, 2025 – For individuals with specific autoimmune conditions, there appears to be an increased risk for affective disorders, according to a study published online June 9 in BMJ...
Exercise Helps Kids' Mood Disorders, Can Serve As Alternative To Meds, Review Finds
MONDAY, June 30, 2025 — Regular exercise can ease mood disorders in children and teens, offering an alternative to medications like antidepressants, a new evidence review has concluded. Both anxiety a...
Autoimmune Diseases Increase Risk Of Mood Disorders
WEDNESDAY, June 25, 2025 — People living with an autoimmune disease are nearly twice as likely to suffer from mood problems like depression, anxiety or bipolar disorder, a new large-scale study says. ...
Federal Addiction And Mental Health Agency Faces Major Staff Cuts
THURSDAY, March 13, 2025 – A key federal agency responsible for addiction and mental health services is facing deep staff cuts. The Substance Abuse and Mental Health Services Administration...
Screen Time Tied to Manic Symptoms in Preteens
MONDAY, Feb. 24, 2025 – Screen time such as social media and video games may be associated prospectively with manic symptoms in early adolescence, according to a study published online Feb. 19 in...
Weight-Obsessed Teens Face Triple the Odds for Self-Harm
WEDNESDAY, Feb. 12, 2025 – Even if a teen is at a healthy weight, just thinking they are overweight can greatly raise their odds for self-harm, a new study finds. “What we found was that the p...
Lithium Linked to Risk for Thyroid Dysfunction, CKD in Bipolar Disorder
WEDNESDAY, Feb. 12, 2025 – Lithium is associated with an increased risk for thyroid dysfunction and chronic kidney disease (CKD) in patients with incident bipolar disorder (BD), according to a study...
Antipsychotics at Doses >75 mg a Day Linked to Risk for Tardive Dyskinesia
FRIDAY, Jan. 17, 2025 – Antipsychotics at doses >75 mg/day are associated with an increased risk for tardive dyskinesia (TD), according to a study recently published in the Journal of Clinical...
Need Some 'Alone Time'? It's Vital to Mental Health for Many
TUESDAY, Dec. 3, 2024 – The hectic holidays play havoc on people’s nerves, not the least because they aren’t able to have any time to themselves. Nearly half (46%) of Americans say they don’t get the...
Fitbit Data Produce Accurate Mood Symptomatology Predictions
TUESDAY, Dec. 3, 2024 – Machine learning shows good performance in detecting mood symptomatology in patients with bipolar disorder (BD) using Fitbit data, according to a study published online Oct....
Risk for Sudden Cardiac Death Elevated for Patients With Psychiatric Disorders
WEDNESDAY, Oct. 23, 2024 – Patients with psychiatric disorders have an increased rate of sudden cardiac death (SCD), according to a study published online Oct. 22 in Heart. Jasmin Mujkanovic, from...
Accelerated Intermittent Theta-Burst Stimulation Aids Treatment-Resistant Bipolar Depression
WEDNESDAY, July 24, 2024 – Accelerated intermittent theta-burst stimulation (aiTBS) is significantly more effective than sham stimulation for depressive symptom reduction in patients with...
Vanda Pharmaceuticals' Fanapt (iloperidone) Receives U.S. FDA Approval for the Acute Treatment of Bipolar I Disorder
WASHINGTON, April 2, 2024 /PRNewswire/ – Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the U.S. Food and Drug Administration (FDA) has approved Fanapt (iloperidone) tablets...
FDA Approves Abilify Asimtufii (aripiprazole) for the Treatment of Schizophrenia or Maintenance Monotherapy Treatment of Bipolar I Disorder in Adults
April 28, 2023 – Otsuka Pharmaceutical Co., Ltd. (Otsuka) and Lundbeck Pharmaceuticals LLC (Lundbeck) announce the U.S. Food and Drug Administration (FDA) has approved the New Drug Application (NDA)...
FDA Approves Rykindo (risperidone) Extended-Release Injectable Suspension for the Treatment of Schizophrenia and Bipolar 1 Disorder
PRINCETON, N.J., Jan. 15, 2023 /PRNewswire/ -- Luye Pharma Group (Luye Pharma), an international pharmaceutical company dedicated to the R&D, manufacturing and sale of innovative medications, today ...
Further information
Related condition support groups
Related drug support groups
gabapentin, sertraline, clonazepam, escitalopram, Seroquel, citalopram, bupropion, Abilify, Lamictal, view more... venlafaxine, lithium, duloxetine, lamotrigine, Latuda, Depakote, quetiapine, topiramate, clonidine, Vraylar, olanzapine, risperidone, Zyprexa, Risperdal, aripiprazole, Seroquel XR, Geodon, oxcarbazepine, levetiracetam, verapamil, desvenlafaxine, lurasidone